Next Article in Journal
Ergot Alkaloids in Fattening Chickens (Broilers): Toxic Effects and Carry over Depending on Dietary Fat Proportion and Supplementation with Non-Starch-Polysaccharide (NSP) Hydrolyzing Enzymes
Next Article in Special Issue
Helicobacter pylori Strains and Gastric MALT Lymphoma
Previous Article in Journal
Venom Profiling of a Population of the Theraphosid Spider Phlogius crassipes Reveals Continuous Ontogenetic Changes from Juveniles through Adulthood
Previous Article in Special Issue
Type IV Secretion and Signal Transduction of Helicobacter pylori CagA through Interactions with Host Cell Receptors

NF‐κB Signaling in Gastric Cancer

Institute of Experimental Internal Medicine, Otto von Guericke University Magdeburg, Magdeburg 39120, Germany
Author to whom correspondence should be addressed.
Toxins 2017, 9(4), 119;
Received: 3 February 2017 / Revised: 14 March 2017 / Accepted: 22 March 2017 / Published: 28 March 2017
(This article belongs to the Special Issue H. pylori Virulence Factors in the Induction of Gastric Cancer)
Gastric cancer is a leading cause of cancer death worldwide. Diet, obesity, smoking and chronic infections, especially with Helicobacter pylori, contribute to stomach cancer development. H. pylori possesses a variety of virulence factors including encoded factors from the cytotoxin‐associated gene pathogenicity island (cagPAI) or vacuolating cytotoxin A (VacA). Most of the cagPAI‐encoded products form a type 4 secretion system (T4SS), a pilus‐like macromolecular transporter, which translocates CagA into the cytoplasm of the host cell. Only H. pylori strains carrying the cagPAI induce the transcription factor NF‐κB, but CagA and VacA are dispensable for direct NF‐κB activation. NF‐κB‐driven gene products include cytokines/chemokines, growth factors, anti‐apoptotic factors, angiogenesis regulators and metalloproteinases. Many of the genes transcribed by NF‐κB promote gastric carcinogenesis. Since it has been shown that chemotherapy‐caused cellular stress could elicit activation of the survival factor NF‐κB, which leads to acquisition of chemoresistance, the NF‐κB system is recommended for therapeutic targeting. Research is motivated for further search of predisposing conditions, diagnostic markers and efficient drugs to improve significantly the overall survival of patients. In this review, we provide an overview about mechanisms and consequences of NF‐κB activation in gastric mucosa in order to understand the role of NF‐κB in gastric carcinogenesis. View Full-Text
Keywords: NF‐κB; inflammation; gastric cancer; Helicobacter pylori; VacA toxin; Type 4 secretion system; tumor microenvironment; chemoresistance NF‐κB; inflammation; gastric cancer; Helicobacter pylori; VacA toxin; Type 4 secretion system; tumor microenvironment; chemoresistance
Show Figures

Figure 1

MDPI and ACS Style

Sokolova, O.; Naumann, M. NF‐κB Signaling in Gastric Cancer. Toxins 2017, 9, 119.

AMA Style

Sokolova O, Naumann M. NF‐κB Signaling in Gastric Cancer. Toxins. 2017; 9(4):119.

Chicago/Turabian Style

Sokolova, Olga, and Michael Naumann. 2017. "NF‐κB Signaling in Gastric Cancer" Toxins 9, no. 4: 119.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop